James Karrels
2022
In 2022, James Karrels earned a total compensation of $1.7M as Senior Vice President, Chief Financial Officer and Corporate Secretary at MacroGenics, a 13% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $167,283 |
|---|---|
| Option Awards | $1,040,858 |
| Salary | $447,346 |
| Other | $12,200 |
| Total | $1,667,687 |
Karrels received $1M in option awards, accounting for 62% of the total pay in 2022.
Karrels also received $167.3K in non-equity incentive plan, $447.3K in salary and $12.2K in other compensation.
Rankings
In 2022, James Karrels' compensation ranked 2,044th out of 5,756 executives tracked by ExecPay. In other words, Karrels earned more than 64.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,044 out of 5,756 | 65th |
Division Manufacturing | 1,100 out of 3,133 | 65th |
Major group Chemicals And Allied Products | 473 out of 1,419 | 67th |
Industry group Drugs | 434 out of 1,320 | 67th |
Industry Pharmaceutical Preparations | 317 out of 966 | 67th |
Source: SEC filing on April 17, 2023.
Karrels' colleagues
We found two more compensation records of executives who worked with James Karrels at MacroGenics in 2022.
News
MacroGenics CEO Scott Koenig's 2023 pay slips 20% to $3.7M
April 8, 2024
MacroGenics CEO Scott Koenig's 2022 pay slips 5% to $4.6M
April 17, 2023
MacroGenics CEO Scott Koenig's 2021 pay jumps 56% to $4.9M
April 8, 2022
MacroGenics Chief Medical Officer Stephen Eck receives $5.1M in 2020
April 1, 2021
MacroGenics CEO Scott Koenig's 2019 pay slips 9% to $4.7M
April 2, 2020